The Duloxetine Delayed-Release Capsules' voluntary recall began on Oct. 10 after the FDA deemed the medication the ...
FDA-approved Cobenfy offers a novel treatment for schizophrenia, targeting cholinergic receptors instead of dopamine, with ...
The U.S. Food and Drug Administration has declined to approve Camurus' drug for the treatment of a rare hormonal disorder due ...
Food companies exploit a loophole in the FDA’s rules that let them self-determine an additive’s safety, yielding obvious ...
The U.S. Food and Drug Administration on Tuesday approved Pfizer's RSV vaccine for the prevention of lower respiratory tract ...
The Food and Drug Administration, in collaboration with the U.S. Customs and Border Protection (CBP), seized about three ...
Patient advocates hope Dr. Michelle Tarver will lead the agency to focus more on safety and less on rapid approvals.
Duloxetine Delayed-Release Capsules were recalled because the pills may contain high levels of a cancer-causing chemical.
The agency posted documents this week that the drugmaker had requested the drug be placed on the FDA's "Demonstrable ...
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO® (Respiratory ...
Abrysvo can prevent lower respiratory tract disease caused by RSV for people between the ages of 18 and 59 who are at ...
Michelle Tarver will be the new leader of the medical devices center at the Food and Drug Administration, according to an ...